Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Complete Mitochondrial Genome Sequencing of a Burial from a Romano-Christian Cemetery in the Dakhleh Oasis, Egypt: Preliminary Indications.

Molto JE, Loreille O, Mallott EK, Malhi RS, Fast S, Daniels-Higginbotham J, Marshall C, Parr R.

Genes (Basel). 2017 Oct 6;8(10). pii: E262. doi: 10.3390/genes8100262.

2.

Human-Based Human Milk Fortifier as Rescue Therapy in Very Low Birth Weight Infants Demonstrating Intolerance to Bovine-Based Human Milk Fortifier.

Sandhu A, Fast S, Bonnar K, Baier RJ, Narvey M.

Breastfeed Med. 2017 Nov;12(9):570-573. doi: 10.1089/bfm.2017.0017. Epub 2017 Aug 4.

3.

Odontogenic myxoma involving the orbit in a 3-year-old boy: removal, reconstruction and review of the literature.

Hansen TS, Danielsson LI, Fast S, Thygesen TH.

BMJ Case Rep. 2016 Feb 17;2016. pii: bcr2015212465. doi: 10.1136/bcr-2015-212465.

4.

Wetlands for Wastewater Treatment.

Martinez-Guerra E, Jiang Y, Lee G, Kokabian B, Fast S, Truax DD, Martin JL, Magbanua BS, Gude VG.

Water Environ Res. 2015 Oct;87(10):1095-126. doi: 10.2175/106143015X14338845155426.

PMID:
26420081
5.

Cost-Effective Control of Infectious Disease Outbreaks Accounting for Societal Reaction.

Fast SM, González MC, Markuzon N.

PLoS One. 2015 Aug 19;10(8):e0136059. doi: 10.1371/journal.pone.0136059. eCollection 2015.

6.

The Role of Social Mobilization in Controlling Ebola Virus in Lofa County, Liberia.

Fast SM, Mekaru S, Brownstein JS, Postlethwaite TA, Markuzon N.

PLoS Curr. 2015 May 15;7. pii: ecurrents.outbreaks.c3576278c66b22ab54a25e122fcdbec1. doi: 10.1371/currents.outbreaks.c3576278c66b22ab54a25e122fcdbec1.

7.

Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiter.

Bonnema SJ, Stovgaard ES, Fast S, Broedbaek K, Andersen JT, Weimann A, Grupe P, Hegedüs L, Poulsen HE.

Eur Thyroid J. 2015 Mar;4(1):20-5. doi: 10.1159/000371883. Epub 2015 Feb 11.

8.

[Buschke-Ollendorff syndrome in two generations imitated Calvé-Legg-Perthes disease].

Ali N, Fast S, Poulsen MR, Bygum A.

Ugeskr Laeger. 2015 Jan 26;177(2A):68-9. Danish.

PMID:
25612973
9.

Modelling the propagation of social response during a disease outbreak.

Fast SM, González MC, Wilson JM, Markuzon N.

J R Soc Interface. 2015 Mar 6;12(104):20141105. doi: 10.1098/rsif.2014.1105.

10.

Full mtGenome reference data: development and characterization of 588 forensic-quality haplotypes representing three U.S. populations.

Just RS, Scheible MK, Fast SA, Sturk-Andreaggi K, Röck AW, Bush JM, Higginbotham JL, Peck MA, Ring JD, Huber GE, Xavier C, Strobl C, Lyons EA, Diegoli TM, Bodner M, Fendt L, Kralj P, Nagl S, Niederwieser D, Zimmermann B, Parson W, Irwin JA.

Forensic Sci Int Genet. 2015 Jan;14:141-55. doi: 10.1016/j.fsigen.2014.09.021. Epub 2014 Oct 5.

11.

[Odontogenic myxoma of the maxilla in a three-year-old boy].

Danielsson LI, Jakobsen J, Thygesen TH, Fast S.

Ugeskr Laeger. 2014 Mar 24;176(13). pii: V11130672. Danish.

PMID:
25349936
12.

The role of radioiodine therapy in benign nodular goitre.

Bonnema SJ, Fast S, Hegedüs L.

Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):619-31. doi: 10.1016/j.beem.2014.02.001. Epub 2014 Feb 16. Review.

PMID:
25047210
13.

Development of forensic-quality full mtGenome haplotypes: success rates with low template specimens.

Just RS, Scheible MK, Fast SA, Sturk-Andreaggi K, Higginbotham JL, Lyons EA, Bush JM, Peck MA, Ring JD, Diegoli TM, Röck AW, Huber GE, Nagl S, Strobl C, Zimmermann B, Parson W, Irwin JA.

Forensic Sci Int Genet. 2014 May;10:73-9. doi: 10.1016/j.fsigen.2014.01.010. Epub 2014 Feb 6.

14.

Substantial interobserver variation of thyroid volume and function by visual evaluation of thyroid (99m)Tc scintigraphy.

Soelberg KK, Grupe P, Boel-Jørgensen H, Jørgensen PH, Fast S, Nielsen VE, Hegedüs L, Bonnema SJ.

Dan Med J. 2014 Feb;61(2):A4768.

PMID:
24495880
15.

Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.

Fast S, Hegedüs L, Pacini F, Pinchera A, Leung AM, Vaisman M, Reiners C, Wemeau JL, Huysmans DA, Harper W, Rachinsky I, de Souza HN, Castagna MG, Antonangeli L, Braverman LE, Corbo R, Düren C, Proust-Lemoine E, Marriott C, Driedger A, Grupe P, Watt T, Magner J, Purvis A, Graf H.

Thyroid. 2014 Apr;24(4):727-35. doi: 10.1089/thy.2013.0370. Epub 2014 Mar 4.

16.

A geometric framework for evaluating rare variant tests of association.

Liu K, Fast S, Zawistowski M, Tintle NL.

Genet Epidemiol. 2013 May;37(4):345-57. doi: 10.1002/gepi.21722. Epub 2013 Mar 21.

17.

Assessing the impact of differential genotyping errors on rare variant tests of association.

Mayer-Jochimsen M, Fast S, Tintle NL.

PLoS One. 2013;8(3):e56626. doi: 10.1371/journal.pone.0056626. Epub 2013 Mar 5.

18.

Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.

Fast S, Nielsen VE, Grupe P, Boel-Jørgensen H, Bastholt L, Andersen PB, Bonnema SJ, Hegedüs L.

J Clin Endocrinol Metab. 2012 Aug;97(8):2653-60. doi: 10.1210/jc.2011-3335. Epub 2012 May 10.

PMID:
22577172
19.

Using online surveillance to monitor EPO dosing.

Fast S, Jobalia A, Ordway F, Luo F.

Nephrol News Issues. 2011 Nov;25(12):24-5. No abstract available.

PMID:
22204157
20.

[Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].

Fast S, Henningsen E, Bygum A.

Ugeskr Laeger. 2011 Oct 10;173(41):2574-5. Danish.

PMID:
21985837
21.

Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.

Bonnema SJ, Fast S, Hegedüs L.

Endocrine. 2011 Dec;40(3):344-53. doi: 10.1007/s12020-011-9542-6. Epub 2011 Oct 5. Review.

PMID:
21971931
22.

Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.

Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS.

Biochem Pharmacol. 2011 Nov 1;82(9):1100-9. doi: 10.1016/j.bcp.2011.07.078. Epub 2011 Jul 23.

23.

Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.

Fast S, Bonnema SJ, Hegedüs L.

Ann Endocrinol (Paris). 2011 Apr;72(2):129-35. doi: 10.1016/j.ando.2011.03.018. Epub 2011 Apr 21. Review.

PMID:
21513911
24.

Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, Reiners C, Wemeau JL, Huysmans D, Harper W, Driedger A, de Souza HN, Castagna MG, Antonangeli L, Braverman L, Corbo R, Düren C, Proust-Lemoine E, Edelbroek MA, Marriott C, Rachinsky I, Grupe P, Watt T, Magner J, Hegedus L.

J Clin Endocrinol Metab. 2011 May;96(5):1368-76. doi: 10.1210/jc.2010-1193. Epub 2011 Feb 23.

PMID:
21346067
25.

Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter.

Bonnema SJ, Fast S, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Hegedüs L.

J Endocrinol Invest. 2011 Mar;34(3):e52-7. doi: 10.3275/7260. Epub 2010 Sep 9.

PMID:
20834199
26.

Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.

Fast S, Hegedüs L, Grupe P, Nielsen VE, Bluhme C, Bastholt L, Bonnema SJ.

J Clin Endocrinol Metab. 2010 Aug;95(8):3719-25. doi: 10.1210/jc.2010-0634. Epub 2010 Jun 2.

PMID:
20519346
27.

Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0.1, 0.3 and 0.9 mg of rhTSH.

Fast S, Nielsen VE, Bonnema SJ, Hegedüs L.

Clin Endocrinol (Oxf). 2010 Mar;72(3):411-6. doi: 10.1111/j.1365-2265.2009.03650.x. Epub 2009 Jun 8.

PMID:
19508679
28.

Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.

Fast S, Nielsen VE, Grupe P, Bonnema SJ, Hegedüs L.

J Nucl Med. 2009 May;50(5):732-7. doi: 10.2967/jnumed.108.060152.

29.

Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.

Fast S, Nielsen VE, Bonnema SJ, Hegedüs L.

Eur J Endocrinol. 2009 Apr;160(4):517-28. doi: 10.1530/EJE-08-0779. Epub 2008 Dec 23. Review.

PMID:
19106244
30.

The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.

Fast S, Bonnema SJ, Hegedüs L.

Clin Endocrinol (Oxf). 2008 Oct;69(4):653-8. doi: 10.1111/j.1365-2265.2008.03241.x. Epub 2008 Mar 17.

PMID:
18363890
31.

Where are the recruiters?

Alexander C, Otto M, Fast S, Tokaryk D, Mardiros M.

Nurs BC. 2002 Feb;34(1):24-5. No abstract available.

PMID:
11924200
32.

Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay.

Rotbart HA, Sawyer MH, Fast S, Lewinski C, Murphy N, Keyser EF, Spadoro J, Kao SY, Loeffelholz M.

J Clin Microbiol. 1994 Oct;32(10):2590-2.

33.

The Stroke Data Bank project: implications for nursing research.

Bronstein K, Murray P, Licata-Gehr E, Banko M, Kelly-Hayes M, Fast S, Kunitz S.

J Neurosci Nurs. 1986 Jun;18(3):132-4.

PMID:
2941498
34.

Biomass energy from crop and forest residues.

Pimentel D, Moran MA, Fast S, Weber G, Bukantis R, Balliett L, Boveng P, Cleveland C, Hindman S, Young M.

Science. 1981 Jun 5;212(4499):1110-5.

PMID:
17815203

Supplemental Content

Support Center